Cancer Targeting Cellular Therapies
Cell Therapies constitutes the largest number of agents in oncology drug development, with currently more than 2000+ Active Cancer Targeting...
Serine/Theonine Kinase Inhibitors
. SERINE / THEONINE KINASE INHIBITORS 1. BRAF/MEK/ERK Inhibitors 2. CDK Inhibitors 3. PI3K/AKT/mTOR Inhibitors Check Also KINASE INHIBITORS -...
Non Receptor Tyrosine Kinase Inhibitors
. NON-RECEPTOR TYROSINE KINASE INHIBITORS 1. Bcr-Abl1 Inhibitors 2. JAK Inhibitors 3. BTK Inhibitors Check Also KINASE INHIBITORS - An...
Receptor Tyrosine Kinase Inhibitors
Protein kinases are the enzymes that catalyzes the transfer of γ-phosphate group from ATP to protein residues containing hydroxyl groups...
Kinase Inhibitors – An Overview
Protein kinases are the enzymes that catalyzes the transfer of γ-phosphate group from ATP to protein residues containing hydroxyl groups...
BiG Pharma – Oncology Insights & Updates
Top 15 Pharma Companies alone comprise of more than 10% of Oncology Drug Development worldwide.
Targeted Cancer Therapies – Antibodies
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.Articles in this...
Small Molecule Epigenetic Drugs in Development – An Overview
EEpigenetics is a branch of genetics that studies the heritable changes of gene expression without changing the nucleotide sequence of...
Small Molecule Epigenetic Inhibitors – 2021
EEpigenetics is a branch of genetics that studies the heritable changes of gene expression without changing the nucleotide sequence of...